Molecular and clinical characterization of a nonsense CDKN1C mutation in an Emirati patient with Beckwith-Wiedemann syndrome

References

1. ↵
   1. Enklaar T,
   2. Zabel BU,
   3. Prawitt D

   (2006) Beckwith-Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med 8:1–19.

   OpenUrlCrossRefPubMed
2. ↵
   1. Lee MH,
   2. Reynisdóttir I,
   3. Massagué J

   (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639–649.

   OpenUrlAbstract/FREE Full Text
3. ↵
   1. Moldovan GL,
   2. Pfander B,
   3. Jentsch S

   (2007) PCNA, the maestro of the replication fork. Cell 129:665–679.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Lam WW,
   2. Hatada I,
   3. Ohishi S,
   4. Mukai T,
   5. Joyce JA,
   6. Cole TR,
   7. et al.

   (1999) Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet 36:518–523.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Greer KJ,
   2. Kirkpatrick SJ,
   3. Weksberg R,
   4. Pauli RM

   (2008) Beckwith-Wiedemann syndrome in adults: observations from one family and recommendations for care. Am J Med Genet A 146A:1707–1712.

   OpenUrlPubMed